Europe Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology, Urolo

Europe Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Detachable Coil and Pushable Coil), By Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), By Application (Neurology, Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Others), and End User (Hospital, Cardiac Center, Ambulatory Center, and Other)

The Europe embolization coils market is expected to grow from US$ 310.02 million in 2022 to US$ 391.22 million by 2028; it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.

Escalation in Patient Preference for Minimally Invasive Procedures

The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-Catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, or anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy is arranged that helps the drug to remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolization coils market growth. In Addition, the rise in the awareness about minimally invasive procedures and availability of the reimbursement for minimally invasive procedures are likely to foster the demand for a minimally invasive procedure. Thus, owing to these factors the Europe embolization coils market is likely to propel significantly in the forecast period.

Europe Embolization Coils Market Overview

The Europe embolization coils market includes France, Germany, United Kingdom, Italy, Spain, and the Rest of Europe. Europe occupies second position in the global embolization coils market and is expected to register robust growth rate over the forecast period. The market is expected to witness robust growth due to the rising prevalence of the renal cancer in Germany and increasing numbers of the investments by the governments of France and United Kingdom. In addition, the rise in the prevalence of stroke is likely to drive the market significantly in the coming future.

Europe Embolization Coils Market Revenue and Forecast to 2028 (US$ Million)

Europe Embolization Coils Market Segmentation

The Europe embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the Europe embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the Europe embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the Europe embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the Europe embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.

Based on country, the Europe embolization coils market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. The Germany dominated the market share in 2022.

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the Europe embolization coils market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe embolization coils market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe embolization coils market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe embolization coils market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution